KIP Infrastructure
2.27.3 -

This page is part of the KIP Infrastructure (v2.27.3: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

CodeSystem: WHO ATC; Mixed codes

Official URL: https://kip.rkkp.dk/fhir/CodeSystem/ATCMixedCodes Version: 2.27.3
Active as of 2022-07-14 Computable Name: ATCMixedCodes

WHO ATC code system; Mixed codes. Link: http://www.whocc.no/atc

This Code system is referenced in the definition of the following value sets:

Properties

This code system defines the following properties for its concepts

NameCodeURITypeDescription
comment comment http://hl7.org/fhir/concept-properties#comment string A string that provides additional detail pertinent to the use or understanding of the concept
effectiveDate effectiveDate http://hl7.org/fhir/concept-properties#effectiveDate dateTime The date at which the concept status was last changed
status status http://hl7.org/fhir/concept-properties#status code A code that indicates the status of the concept. Typical values are active, experimental, deprecated, and retired
Inactive inactive http://hl7.org/fhir/concept-properties#inactive boolean True if the concept is not considered active - e.g. not a valid concept any more. Property type is boolean, default value is false. Note that the status property may also be used to indicate that a concept is inactive

Concepts

This case-sensitive code system https://kip.rkkp.dk/fhir/CodeSystem/ATCMixedCodes defines the following codes in an undefined hierarchy:

LvlCodeDisplayDefinition
1 tki TKI (Tyrosine kinase inhibitors) TKI (Tyrosine kinase inhibitors)
2   L01EA BCR-ABL tyrosine kinase inhibitors
2   L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
2   L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
2   L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
2   L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors

Description of the above table(s).